Page 87 - ADULT-ONSET ASTHMA PREDICTORS OF CLINICAL COURSE AND SEVERITY

DIAGNOSTIC ACCURACY OF MINIMALLY INVASIVE MARKERS FOR DETECTION OF AIRWAY EOSINOPHILIA IN ASTHMA
REFERENCES
1. Global Ini a ve for Asthma. Global Strategy for Asthma Management and Preven on 2014. Available from: www ginasthma org 2014.
2. McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. American Journal of Respiratory and Cri cal Care Medicine 2012; 185(6):612-619.
3. Petsky HL, Kynaston JA, Turner C, Li AM, Cates CJ, Lasserson TJ et al. Tailored interven ons based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2007;(2):CD005603.
4. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ et al. Interna onal ERS/ATS guidelines on de ni on, evalua on and treatment of severe asthma. Eur Respir J 2014; 43(2):343-373.
5. Ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent air ow limita on in severe asthma. American Journal of Respiratory and Cri cal Care Medicine 2001; 164(5):744-748.
6. Love CJ, Whitehead BF, Gibson PG. Eosinophilic airway in amma on and the prognosis of childhood asthma. Clinical and Experimental Allergy 2007; 37(11):1594-1601.
7. Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON et al. Mepolizumab for severe eosinophilic asthma (DREAM): a mul centre, double-blind, placebo-controlled trial. Lancet 2012; 380(9842):651-659.
8. Lee ang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Systema c reviews of diagnos c test accuracy. Ann Intern Med 2008; 149(12):889-897.
9. Kim MA, Shin YS, Pham le D, Park HS. Adult asthma biomarkers. Curr Opin Allergy Clin Immunol 2014; 14(1):49-54.
10. Whi ng PF, Rutjes AW, Westwood ME, Malle S, Deeks JJ, Reitsma JB et al. QUADAS-2: a revised tool for the quality assessment of diagnos c accuracy studies. Ann Intern Med 2011; 155(8):529-536.
11. Zhou XH, Obuchowski NA, McClish DK. Sta s cal methods in diagnos c medicine. New York: Wiley.; 2002.
12. Higgins JP, Thompson SG. Quan fying heterogeneity in a meta-analysis. Stat Med 2002; 21(11):1539-1558.
13. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publica on bias and other sample size e ects in systema c reviews of diagnos c test accuracy was assessed. J Clin Epidemiol 2005; 58(9):882-893.
14. Wagener A, de Nijs S, Lu er R, Sousa A, Weersink E, Bel E et al. External valida on of blood eosinophils, FeNO, and serum perios n as surrogates for sputum eosinophils in asthma. Thorax 2014; 70(2):115-20.
15. Korevaar DA, Wang J, van Enst WA, Lee ang MM, Hoo L, Smidt N et al. Repor ng Diagnos c Accuracy Studies: Some Improvements a er 10 Years of STARD. Radiology 2014;141160 [Epub ahead of print].
16. Korevaar DA, Ochodo EA, Bossuyt PM, Hoo L. Publica on and repor ng of test accuracy studies registered in ClinicalTrials.gov. Clin Chem 2014; 60(4):651-659.
17. Korevaar DA, Bossuyt PM, Hoo L. Infrequent and incomplete registra on of test accuracy studies: analysis of recent study reports. BMJ Open 2014; 4(1):e004596.
18. Grootendorst DC, Sont JK, Willems LN, Kluin-Nelemans JC, Van Krieken JH, Veselic-Charvat M et al. Comparison of in ammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy 1997; 27(7):769-779.
19. van der Schee MP, Palmay R, Cowan JO, Taylor DR. Predic ng steroid responsiveness in pa ents with asthma using exhaled breath pro ling. Clin Exp Allergy 2013; 43(11):1217-1225.
85